Search by Drug Name or NDC

    NDC 65862-0011-05 Sertraline Hydrochloride 25 mg/1 Details

    Sertraline Hydrochloride 25 mg/1

    Sertraline Hydrochloride is a ORAL TABLET, FILM COATED in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Aurobindo Pharma Limited. The primary component is SERTRALINE HYDROCHLORIDE.

    Product Information

    NDC 65862-0011
    Product ID 65862-011_4680748c-467b-4a7c-9387-848919a206bc
    Associated GPIs 58160070100305
    GCN Sequence Number 046227
    GCN Sequence Number Description sertraline HCl TABLET 25 MG ORAL
    HIC3 H2S
    HIC3 Description SELECTIVE SEROTONIN REUPTAKE INHIBITOR (SSRIS)
    GCN 16373
    HICL Sequence Number 006324
    HICL Sequence Number Description SERTRALINE HCL
    Brand/Generic Generic
    Proprietary Name Sertraline Hydrochloride
    Proprietary Name Suffix n/a
    Non-Proprietary Name Sertraline Hydrochloride
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET, FILM COATED
    Route ORAL
    Active Ingredient Strength 25
    Active Ingredient Units mg/1
    Substance Name SERTRALINE HYDROCHLORIDE
    Labeler Name Aurobindo Pharma Limited
    Pharmaceutical Class Cytochrome P450 2D6 Inhibitors [MoA], Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA077206
    Listing Certified Through 2024-12-31

    Package

    NDC 65862-0011-05 (65862001105)

    NDC Package Code 65862-011-05
    Billing NDC 65862001105
    Package 500 TABLET, FILM COATED in 1 BOTTLE (65862-011-05)
    Marketing Start Date 2007-02-06
    NDC Exclude Flag N
    Pricing Information
    Price Per Unit 0.03179
    Pricing Unit EA
    Effective Date 2024-02-21
    NDC Description SERTRALINE HCL 25 MG TABLET
    Pharmacy Type Indicator C/I
    OTC N
    Explanation Code 1
    Classification for Rate Setting G
    As of Date 2024-02-21
    This pricing file, entitled the NADAC (National Average Drug Acquisition Cost) files, provide state Medicaid agencies with covered outpatient drug prices by averaging survey invoice prices from retail community pharmacies across the United States. These pharmacies include independent retail community pharmacies and chain pharmacies. The prices are updated on a weekly and monthly basis